Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Protective Effect of Valsartan on Beleomycine-Induced Fibrosis

Hoda Mojiri Forushani 1 , Ali Asghar Hemmati 1 , * , Ali Khodadadi 2 , Mohammad-Ali Assarehzadegan 3 and Mohammad Rashno 2
Authors Information
1 Pharmacology Department ,School of Pharmacy and Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Immunology Department, School of Medicine, Ahvaz Jundishapur University of Medical Sciences (AJUMS), Ahvaz, Iran
3 Immunology Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 2017, 12 (1); e33973
  • Published Online: September 4, 2016
  • Article Type: Research Article
  • Received: November 7, 2015
  • Revised: May 13, 2016
  • Accepted: May 29, 2016
  • DOI: 10.5812/jjnpp.33973

To Cite: Mojiri Forushani H, Hemmati A A, Khodadadi A, Assarehzadegan M, Rashno M. Protective Effect of Valsartan on Beleomycine-Induced Fibrosis, Jundishapur J Nat Pharm Prod. 2017 ; 12(1):e33973. doi: 10.5812/jjnpp.33973.

Abstract
Copyright © 2016, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006; 61(11): 980-5[DOI][PubMed]
  • 2. Selman M, Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res. 2002; 3: 3[PubMed]
  • 3. Green FH. Overview of pulmonary fibrosis. Chest. 2002; 122(6 Suppl): 334-9[PubMed]
  • 4. Ozyurt H, Sogut S, Yildirim Z, Kart L, Iraz M, Armutcu F, et al. Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clin Chim Acta. 2004; 339(1-2): 65-75[PubMed]
  • 5. Pardo A, Ruiz V, Arreola JL, Ramirez R, Cisneros-Lira J, Gaxiola M, et al. Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. Am J Respir Crit Care Med. 2003; 167(6): 925-32[DOI][PubMed]
  • 6. Shenoy V, Ferreira AJ, Qi Y, Fraga-Silva RA, Diez-Freire C, Dooies A, et al. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med. 2010; 182(8): 1065-72[DOI][PubMed]
  • 7. Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T, et al. Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2004; 286(1)-64[DOI][PubMed]
  • 8. Marshall RP, McAnulty RJ, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med. 2000; 161(6): 1999-2004[DOI][PubMed]
  • 9. Papp M, Li X, Zhuang J, Wang R, Uhal BD. Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II. Am J Physiol Lung Cell Mol Physiol. 2002; 282(4): 713-8[DOI][PubMed]
  • 10. Li X, Rayford H, Uhal BD. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. Am J Pathol. 2003; 163(6): 2523-30[DOI][PubMed]
  • 11. Molteni A. Editorial Part-II: Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update. Curr Pharm Des. 2007; 13(13): 1295-8[PubMed]
  • 12. Couluris M, Kinder BW, Xu P, Gross-King M, Krischer J, Panos RJ. Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project. Lung. 2012; 190(5): 523-7[DOI][PubMed]
  • 13. Black HR, Bailey J, Zappe D, Samuel R. Valsartan: more than a decade of experience. Drugs. 2009; 69(17): 2393-414[DOI][PubMed]
  • 14. Schraufnagel DE, Mehta D, Harshbarger R, Treviranus K, Wang NS. Capillary remodeling in bleomycin-induced pulmonary fibrosis. Am J Pathol. 1986; 125(1): 97-106[PubMed]
  • 15. Woessner JFJ. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961; 93: 440-7[PubMed]
  • 16. Lasky JA, Ortiz LA. Antifibrotic therapy for the treatment of pulmonary fibrosis. Am J Med Sci. 2001; 322(4): 213-21[PubMed]
  • 17. Otsuka M, Takahashi H, Shiratori M, Chiba H, Abe S. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. Thorax. 2004; 59(1): 31-8[PubMed]
  • 18. Grafe M, Auch-Schwelk W, Zakrzewicz A, Regitz-Zagrosek V, Bartsch P, Graf K, et al. Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res. 1997; 81(5): 804-11[PubMed]
  • 19. Ito H, Takemori K, Suzuki T. Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury. J Hypertens. 2001; 19(3 Pt 2): 591-7[PubMed]
  • 20. Uhal BD, Wang R, Laukka J, Zhuang J, Soledad-Conrad V, Filippatos G. Inhibition of amiodarone-induced lung fibrosis but not alveolitis by angiotensin system antagonists. Pharmacol Toxicol. 2003; 92(2): 81-7[PubMed]
  • 21. Molina-Molina M, Serrano-Mollar A, Bulbena O, Fernandez-Zabalegui L, Closa D, Marin-Arguedas A, et al. Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis. Thorax. 2006; 61(7): 604-10[DOI][PubMed]
  • 22. Long X, Xiong SD, Xiong WN, Xu YJ, Zhang ZX, Cao Y, et al. Losartan inhibited angiotensin induced human lung fibroblast transformation and collagen synthesis [in Chinese]. Zhonghua Jie He He Hu Xi Za Zhi. 2007; 30(4): 273-8[PubMed]
  • 23. Yao HW, Zhu JP, Zhao MH, Lu Y. Losartan attenuates bleomycin-induced pulmonary fibrosis in rats. Respiration. 2006; 73(2): 236-42[DOI][PubMed]
  • 24. Ghazi-Khansari M, Mohammadi-Karakani A, Sotoudeh M, Mokhtary P, Pour-Esmaeil E, Maghsoud S. Antifibrotic effect of captopril and enalapril on paraquat-induced lung fibrosis in rats. J Appl Toxicol. 2007; 27(4): 342-9[DOI][PubMed]
  • 25. Marut W, Kavian N, Servettaz A, Hua-Huy T, Nicco C, Chereau C, et al. Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade. Arthritis Rheum. 2013; 65(5): 1367-77[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments